TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Exclusion Criteria

• •known statin intolerance
• •known hypogonadism
• •persistent forms of atrial fibrillation
• •active malignant neoplasm requiring treatment at the time of screening
• •known chronic inflammatory diseases (rheumatoid arthritis, systemic connective tissue diseases, metabolically associated fatty liver disease, etc.)
• •impaired renal function (estimated glomerular filtration rate \<30 ml/min/1.73 m2) and liver (transaminase levels more than 3 times reference values, bilirubin levels more than 2 times reference values)
• •chronic heart failure
• •a well-known diagnosis of mental illness
• •alcoholism and drug addiction
• •glucocorticoid therapy and regular therapy with nonsteroidal anti-inflammatory drugs (80% of the time for 3 months before switching on)
• •participation in any other clinical trial during this trial, including participation in the trial for 30 days prior to providing informed consent
• •the patient's inability to understand the essence of the study and consent to participate in it